Ann Marie Navar, MD, PhD

Assistant Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail 2400 Pratt St., Box 3850, Durham, NC 27705
Phone (919) 684-8111
In Their Words

Education and Training

  • Cardiovascular Disease Fellowship, Duke University School of Medicine, 2013 - 2016
  • Internal Medicine and Pediatrics Residency, Duke University School of Medicine, 2009 - 2013
  • Ph.D., Johns Hopkins University, 2009
  • M.D., Duke University School of Medicine, 2009
  • M.H.S., Johns Hopkins University, 2005

Publications

Navar, AM, Peterson, ED, and Wojdyla, D. "Temporal Changes in the Association Between Modifiable Risk Factors and Coronary Heart Disease Incidence (vol 316, pg 2041, 2016)." JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 316, no. 22 (December 13, 2016): 2433-2433.

Scholars@Duke

Goldstein, BA, Navar, AM, and Pencina, MJ. "Risk Prediction With Electronic Health Records: The Importance of Model Validation and Clinical Context." Jama Cardiology 1, no. 9 (December 2016): 976-977.

PMID
27732706
Full Text

Goldstein, BA, Navar, AM, and Pencina, MJ. "YY Risk Prediction With Electronic Health Records." JAMA CARDIOLOGY 1, no. 9 (December 2016): 976-977.

Full Text

Fanaroff, AC, Navar, AM, Clare, R, Lokhnygina, Y, Roe, M, Giugliano, R, Tershakovec, A, and Blazing, M. "Association of Type of Presentation, STEMI vs NSTEMI/UA, With the Relative Long-Term Incidence of Cardiovascular and Non-Cardiovascular Mortality." November 11, 2016.

Scholars@Duke

Whelton, PK, Einhorn, PT, Muntner, P, Appel, LJ, Cushman, WC, Diez Roux, AV, Ferdinand, KC, Rahman, M, Taylor, HA, Ard, J, Arnett, DK, Carter, BL, Davis, BR, Freedman, BI, Cooper, LA, Cooper, R, Desvigne-Nickens, P, Gavini, N, Go, AS, Hyman, DJ, Kimmel, PL, Margolis, KL, Miller, ER, Mills, KT, Mensah, GA, Navar, AM, Ogedegbe, G, Rakotz, MK, Thomas, G, Tobin, JN, Wright, JT, Yoon, SSS, and Cutler, JA. "Research Needs to Improve Hypertension Treatment and Control in African Americans." Hypertension (Dallas, Tex. : 1979) 68, no. 5 (November 1, 2016): 1066-1072.

Scholars@Duke

Navar, AM, Pencina, MJ, and Peterson, ED. "Assessing Cardiovascular Risk to Guide Hypertension Diagnosis and Treatment." Jama Cardiology 1, no. 8 (November 2016): 864-871.

PMID
27604060
Full Text

Whelton, PK, Einhorn, PT, Muntner, P, Appel, LJ, Cushman, WC, Diez Roux, AV, Ferdinand, KC, Rahman, M, Taylor, HA, Ard, J, Arnett, DK, Carter, BL, Davis, BR, Freedman, BI, Cooper, LA, Cooper, R, Desvigne-Nickens, P, Gavini, N, Go, AS, Hyman, DJ, Kimmel, PL, Margolis, KL, Miller, ER, Mills, KT, Mensah, GA, Navar, AM, Ogedegbe, G, Rakotz, MK, Thomas, G, Tobin, JN, Wright, JT, Yoon, SSS, Cutler, JA, National Heart, Lung, and and Blood Institute Working Group on Research Needs to Improve Hypertension Treatment and Control in African Americans, . "Research Needs to Improve Hypertension Treatment and Control in African Americans." Hypertension (Dallas, Tex. : 1979) 68, no. 5 (November 2016): 1066-1072. (Review)

PMID
27620388
Full Text

Navar, AM, Peterson, ED, Wojdyla, D, Sanchez, RJ, Sniderman, AD, D'Agostino, RB, and Pencina, MJ. "Temporal Changes in the Association Between Modifiable Risk Factors and Coronary Heart Disease Incidence." Jama 316, no. 19 (November 2016): 2041-2043. (Letter)

PMID
27838711
Full Text

Navar, AM, and Peterson, ED. "Evolving Approaches for Statins in Primary Prevention: Progress, but Questions Remain." Jama 316, no. 19 (November 2016): 1981-1983.

PMID
27838704
Full Text

Navar, AM, Stone, NJ, and Martin, SS. "What to say and how to say it: effective communication for cardiovascular disease prevention." Current opinion in cardiology 31, no. 5 (September 2016): 537-544.

PMID
27428113
Full Text

Pages